Filling in a symptom diary: Each patient will receive a diary form in which they are asked to record their symptoms, body temperature, and body weight on a daily basis. This approach is intended to provide a comprehensive overview of the disease course and the impact of treatment over time.
Depending on hospitalization status, disease severity, treatment progress, and national treatment guidelines, clinical, microbiological, and radiological follow-up assessments will be performed as part of routine care at intervals ranging from weekly to monthly. No additional study visits or microbiological or radiological diagnostics outside of standard clinical care will be conducted.
Study summary
The primary aim of the study is to investigate the correlation between patient-reported symptoms recorded in the diary and the microbiological and radiological disease course in patients with pulmonary infections caused by nontuberculous mycobacteria (NTM).
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Pulmonary NTM infection according to ATS/IDSA criteria (1)
* Age ≥ 18 years
* Ability to provide informed consent
* Willingness to participate in the study AND
* Clinical decision to initiate antimicrobial therapy as part of routine care
* Cohort 1 OR
* Clinical decision against antimicrobial therapy as part of routine care
* Cohort 2
Exclusion Criteria:
* Lack of ability to provide informed consent
* Language barriers that prevent completion of the diary
* Antimicrobial therapy for the NTM infection already initiated
Primary outcome measure(s)
Degree of correlation of the symptom diary with radiology — 6 months from enrolement The primary endpoint of the study is the degree of correlation between patient-reported symptoms recorded in the diary in patients with pulmonary infections caused by nontuberculous mycobacteria (NTM) and the radiological course of the disease.
Radiological course of the disease is assessed by a radiological composit measure consisting of an ordinal scale for nodule extent, consolidation extent, bronchiectasis severity and -extent, mucus plugging, cellular bronchiolitis severity and -extent, cavity diameter, -wall thickness, and number of cavities. Worsening (+1, step up) and improvement (-1 step down) are added and show overall worsening (\>= +1), overall improvement (\<= -1) or stable disease (= +/-0).
Degree of correlation of the symptom diary with microbiology — 6 months from enrolment The primary endpoint of the study is the degree of correlation between patient-reported symptoms recorded in the diary in patients with pulmonary infections caused by nontuberculous mycobacteria (NTM) and the microbiological course of the disease, assessed by
\- the mycobacterial load in sputum microscopy
Degree of correlation of the symptom diary with microbiology — 6 months from enrolment The primary endpoint of the study is the degree of correlation between patient-reported symptoms recorded in the diary in patients with pulmonary infections caused by nontuberculous mycobacteria (NTM) and the microbiological course of the disease, assessed by
\- time to positivity in liquid culture
Degree of correlation of the symptom diary with microbiology — 6 months from enrolment The primary endpoint of the study is the degree of correlation between patient-reported symptoms recorded in the diary in patients with pulmonary infections caused by nontuberculous mycobacteria (NTM) and the microbiological course of the disease, assessed by
\- treatment duration until culture conversion (defined as the absence of detectable mycobacteria using the aforementioned methods)
Trial sites (3)
Facility
City
Region
Status
Abteilung Infektiologie, Klinik für Innere Medizin II, Universitätsklinikum Freiburg
Freiburg im Breisgau
Baden-Wurttemberg
Not Yet Recruiting
Schwerpunkt Infektiologie, Medizinische Klinik 2, Zentrum für Innere Medizin, Universitätsmedizin Frankfurt
Frankfurt am Main
Hesse
Not Yet Recruiting
Pulmonary Care Center, Research Center Borstel, Leibniz Lung Center
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.